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Abstract
Objective
A clinical decision support system (CDSS) for empirical antibiotic treatment has the potential
to increase appropriate antibiotic use. Before using such a system on a broad scale, it
needs to be tailored to the users preferred way of working. We have developed a CDSS for
empirical antibiotic treatment in hospitalized adult patients. Here we determined in a usabil-
ity study if the developed CDSS needed changes.
Methods
Four prespecified patient cases, based on real life clinical scenarios, were evaluated by 8
medical residents in the study. The “think-aloud” method was used, and sessions were
recorded and analyzed afterwards. Usability was assessed by 3 evaluators using an aug-
mented classification scheme, which combines the User Action Framework with severity rat-
ing of the usability problems and the assessment of the potential impact of these problems
on the final task outcomes.
Results
In total 51 usability problems were identified, which could be grouped into 29 different cate-
gories. Most (n = 17/29) of the usability problems were cosmetic problems or minor prob-
lems. Eighteen (out of 29) of the usability categories could have an ordering error as a
result. Classification of the problems showed that some of the problems would get a low pri-
ority based on their severity rating, but got a high priority for their impact on the task out-
come. This effectively provided information to prioritize system redesign efforts.
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Conclusion
Usability studies improve lay-out and functionality of a CDSS for empirical antibiotic treat-
ment, even after development by a multidisciplinary system.
Introduction
Misuse and overuse of antimicrobial drugs have contributed to the selection of resistant bacte-
ria, which occurs worldwide and has been estimated to contribute to an extra mortality of 10
million people by 2050 [1]. Studies have shown that about 30–50% of antibiotics are being pre-
scribed inappropriately [2–4], and empirically started antibiotics are considered appropriate in
only around 60% of the prescriptions [5–7]. Guideline-adherent empirical therapy is associ-
ated with a relative risk reduction for mortality of 35% and is therefore described as one of the
most important objectives of antimicrobial stewardship programs [8, 9]. The use of a clinical
decision support system (CDSS) is a promising method to improve guideline-adherent empiri-
cal therapy [10–14]. As part of antimicrobial stewardship, a CDSS can play an important role
to prescribe antimicrobial drugs appropriately and according to the guidelines.
CDSSs to support appropriate use of antibiotics have been developed since 1980 [15] and
have increased in number in the last years. These systems combine relevant individual patient
information with a computerized knowledge base to support decision-making in individual
patients. By integrating relevant clinical data and evidence-based guidelines, these systems can
help physicians to effectively manage all relevant information necessary for decision making in
an increasingly complex clinical practice environment [16]. These systems are considered
potentially highly valuable tools to improve clinical decision making and thereby quality of
healthcare [15, 16]. CDSSs to support appropriate use of antibiotics target a variety of aspects,
such as optimizing antimicrobial dosing [17–19] or supporting antimicrobial de-escalation
[20, 21]. Most of these systems however focus on antimicrobial prescribing [15, 22, 23]. It has
been shown that CDSS can increase confidence of general practitioners in their antibiotic pre-
scriptions [24]. The systems that are designed to support antimicrobial prescribing in second-
ary care tend to focus more on a broader population than in primary care, where the systems
are often focused on specific syndrome presentation in adults [15]. We have developed a
CDSS for empirical antibiotic treatment in hospitalized adult patients, which combines rele-
vant patient information with relevant local antibiotic treatment guidelines. Several other
CDSSs for empirical antibiotic prescription have been developed. These CDSS differ on differ-
ent aspects. Some systems use expert rules to predict the pathogen’s susceptibility to antibiot-
ics, using antibiotic susceptibility profiles from patients with similar characteristics [11, 13,
25], but don’t take into account for example the antibiotic resistance history of the patients of
interests or presence of neutropenia [13, 25], like our system does. Others use causal probabi-
listic networks to predict the probability of a bacterial infection, site of infection and pathogens
and their susceptibility to antibiotics. The CDSS we developed generates antibiotic advices
based on relevant guidelines. Like many other CDSS for empirical antibiotic therapy input of
the physicians was needed in our system for the generation of an antibiotic advice [10–13, 25].
CDSS for empirical antibiotic therapy have shown benefits in terms of improving empirical
antibiotic prescribing [10–14]. However, in many of these studies the CDSS was not assessed
while or after the end-users, the physicians themselves, used the system[10, 12, 13].
An important issue with the implementation of CDSSs is that they are, until now, not fre-
quently used despite their potential benefits [26]. Studies have shown that poor usability
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negatively affects CDSS acceptance and effectiveness [27, 28]. Poorly designed CDSS have a
negative impact on the use of these systems and can result in medication errors, potentially
compromising patient safety [27, 28]. Therefore, the usability of these systems need to be well
tested before being implemented in clinical practice. For this purpose we used an augmented
classification scheme developed by Khajouei et al.[27] to test the usability of our developed
CDSS for empirical antimicrobial therapy. This augmented classification scheme combines the
User Action Framework (UAF), a standardized validated classification framework, with sever-
ity rating of the usability problems and the assessment of the potential (clinical) impact of
these problems on the final task outcomes [27]. To our knowledge no other studies have
assessed and described the usability of a developed CDSS for antimicrobial drug prescription
using this systematic framework.
The aim of this study was to detect usability problems in our developed CDSS for empirical
antimicrobial therapy, to rate the severity of these problems, and to determine the impact on
the task outcome.
Materials and methods
Setting
This study was conducted at the Erasmus MC, University Medical Center in Rotterdam, the
Netherlands, a tertiary care center with all medical specialties available. The Erasmus MC uses
an electronic health record (EHR) with integrated computerized prescriber order entry
(CPOE) which was introduced in December 2001.
Clinical decision support system (CDSS)
A rule-based CDSS for empirical antibiotic treatment in adult patients was built as a web appli-
cation by a multidisciplinary team of clinical experts and information and communications
technology (ICT) professionals (Fig 1). The system has been developed to give empirical anti-
biotic treatment advice for the following infections: pneumonia, sepsis, urinary tract infec-
tions, meningitis and secondary peritonitis.
Fig 1. The developed CDSS, which combines relevant electronic patient information with relevant local antibiotic
treatment guidelines.
https://doi.org/10.1371/journal.pone.0223073.g001
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The developed CDSS combines relevant electronic patient information derived from the
Erasmus MC electronic medical record (such as kidney function, microbiological results from
the previous 6 months and presence or absence of neutropenia) with relevant local antibiotic
treatment guidelines, which are in line with national guidelines (http://www.swabid.nl). The
result is an indication driven advice that is patient specific and in accordance with current
guidelines. Relevant patient information were as much as possible automatically extracted
from our HER, to which the CDSS was connected. To generate an appropriate antibiotic
advice some information input, which could not be automatically extracted from our hospital
information system, had to be entered manually by the user (for example the working
diagnosis).
Testing the usability of the CDSS
To identify usability problems in the design of a CDSS, different usability evaluation methods
can be used. One of the methods to assess usability is the use of surveys, for example the often
used System Usability Scale [29, 30]. This is a validated survey instrument, which consists of
10 items that have to be rated on a 5-point agreement scale [29]. It is a relative quick and easy
instrument to use and it covers areas such as user satisfaction, efficiency of use and system
effectiveness [31]. This method has already been used for assessing the usability of a CDSS for
antibiotic prescription [24, 32]. We did not use this survey instrument, because it does not pro-
vide insight in details or causes of identified problems. Other usability evaluation methods,
which are often used are the heuristic evaluation, the cognitive walkthrough and the think
aloud method [33]. The first two mentioned methods are expert-based methods, whereas the
think aloud method is a user-based method. With the heuristic evaluation potential usability
problems are uncovered using heuristics, which are recognized usability principles [34]. An
example of a heuristic is ‘provide help and documentation’. We did not use this method
because the used heuristics are often very generally described, making them multi interpret-
able, resulting in different outcomes. This method is also highly dependent on skills and expe-
rience of the evaluator to improve the results overall [33]. With the cognitive walkthrough a
usability expert simulates a new user by walking through the system step-by-step using typical
tasks and details about the user’s background. This is a really structured approach, however it
is a very tedious method, time consuming and the results are affected by the task description
and given details about the user’s background [33]. We have chosen to use the think aloud
method [35], because this method is a very rich source of data regarding usability problems.
This is a user-based usability evaluation method where participants have to verbalize their
thoughts during the execution of a set of specified tasks. It provides detailed insight into usabil-
ity problems actually experienced by end-users of the system. Of added value is that this
method provides insight in the causes of the identified problems. The verbal data are used to
evaluate the system’s design on usability flaws.
The usability study was performed in 2 steps. During the first step residents completed
tasks using the CDSS and during the second step the usability of the system was assessed using
the data that were collected during the first step. During the first step 15 medical and surgical
residents were invited by e-mail to participate in the study. Residents were invited as partici-
pants in this study, because they are the intended users of the CDSS. Selection of residents was
based on: I) diversity in discipline, II) prescribers of different antimicrobial drugs, III) years of
residency and IV) not being involved in the development or analysis of the CDSS. Eight resi-
dents (3 from internal medicine, 2 from surgery, 2 from medical microbiology, 1 from neurol-
ogy) participated in this study. The residents were on average 31 years old, and in their first to
6th year(s) of residency and 4 were female.
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The residents were given a short demonstration of the CDSS before the usability test. The
CDSS was not used in hospital before the study. Four test cases were developed based on real
life clinical scenarios (for description of these test cases see S1 Table). The test cases were
assessed on correctness, completeness and clearness by clinical experts in our study team. Dur-
ing the usability test, participants were asked to complete the tasks of antimicrobial drug pre-
scription while an observer watched, listened with minimum interruption and recorded
(audiotaped and videotaped) the entire test session. All participants used the same web
browser during the test and completed all four test cases.
Evaluating the usability of the CDSS
During the second step usability of the system was assessed using the data that were collected
during the first step. This assessment was done by 3 unblinded evaluators, a physician, a hospi-
tal pharmacist experienced in clinical decision support and a researcher in the field of quality.
Assessment was done by 2 evaluators, independently of each other. One of these primary eval-
uators had not been involved in the development of the CDSS. Disagreements in the sets of
usability problems were resolved in discussion with a third evaluator. For this assessment an
augmented classification scheme developed by Khajouei et al. was used [27]. This augmented
classification scheme combines the User Action Framework (UAF), a standardized validated
classification framework, with severity rating of the usability problems and the assessment of
the potential (clinical) impact of these problems on the final task outcomes [27]. Each cycle of
the user system interaction, which contains 4 phases (planning, translation, physical actions
and assessment) was assessed. Planning is the phase of the user system interaction cycle includ-
ing all cognitive actions by users to determine what to do. In the translation phase users deter-
mine how to accomplish the intentions that emerge during the planning phase. The phase in
which the actions are being carried out by manipulating user interface objects is the physical
action phase. The assessment phase is about the perception, interpretation and evaluation of
the resulting system state by the user. Usability problems were identified using the videotapes
of the cases and classified under different subcategories to the most detailed level using the
UAF hierarchy [27]. Severity rating of usability problems was performed using the Nielsen’s
classification [35]. This severity rating is based on the (potential) impact of the problem on the
users, the (potential) persistence of the problem and the frequency with which a problem
(might) occur(red).
Results
In total, 51 usability problems were identified in the usability evaluation studies, of which 7 in
the planning phase (Table 1), 28 in the translation phase (Table 2), 4 in the physical actions
phase (Table 3) and 12 in the assessment phase (Table 4). These 51 usability problems could be
grouped into 29 different categories. A description and illustration of some of these usability
problems can also be found in Figs 2 and 3. Fig 4 shows the final screen with a patient specific
antibiotic advice generated.
Planning
Seven (14%) of the identified usability problems were found in the planning phase of user-sys-
tem interaction (Table 1). The usability problems in this phase were mainly caused by the
user’s difficulties in choosing the correct diagnosis (two possible pathways), lack of a third
option such as an ‘unknown’ button, and perceived lack of information (user is not provided
with information about the system state, when entering a new patient identification number
fails).
Improving a clinical decision support system for the prescription of antibiotic drugs
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Classification of the problems with the augmented scheme showed that some of the prob-
lems would get a low priority based on their severity rating, but got a high priority for their
impact on the task outcome. For example, the severity of the usability problems leading to the
prescription of wrong antibiotics was rated as minor or no problem while the impact of pre-
scribing the wrong antibiotic can be high.
Translation
Twenty-eight (55%) of the usability problems concerned the translation phase (Table 2). The
usability problems in this phase were mainly caused by the fact that the mouse over functions
were not noticed or correctly used, and that extra patient information (culture results) were
not noticed by users. Also, the needed doses of gentamicin and the BMI were calculated with a
calculator outside the system or guessed, leading to wrong dose advices.
Most usability problems had low severity ratings. Only one usability catastrophe (severity
rating of 4) was observed when the gentamicin dose had to be calculated and users did look for
a calculator, which was not available in the CDSS. The users expressed the need for a calcula-
tor. Not only the usability problem had a high severity rating of 4, but the impact of the prob-
lem is high too.
Physical actions
Four (8%) of the usability problems were encountered in the phase of physical actions
(Table 3). One of these usability problems was caused by the layout of an object, for instance
the scroll down button that had to be used. Another usability problem in this phase was the
lack of user control over screen objects as these objects were being manipulated. For example,
the user tried to click through the resistance viewer, but this was not possible. Two usability
problems in this phase concerned the failure of the system to meet specific preferences of users
Table 1. Usability problems in the UAF planning phase with their severity and potential effect on task outcome.
ID
No.
Level 1 Level 2 Level 3 Level
4
Description of usability problem No.1 Severity Identifying
potential
outcomes2
1 Planning Users model of the
system
Users ability to
determine what to
do first
It is not immediately clear for the user which diagnosis
has to be chosen in case of urosepsis (two possible
pathways). The first information input that had to be
entered manually by the user is the diagnosis. This is
done by selecting one of the diagnosis in a drop down
menu. For the diagnosis urosepsis the user has two
possible pathways, namely the user can select sepsis,
with sepsis focus urogenital tract or high urinary tract
infection.
3 2 None (both
pathways same
result)
2 Goal decomposition Users ability to
determine what to
do next
User has to answer if patient has an aspiration
pneumonia. Because user doesn’t know user chooses the
answer ‘no’. The option ‘unknown’ does not exist in the
system.
1 0 Wrong antibiotic
3 Goal decomposition Users ability to
determine what to
do next
Information is missing about what has to be filled in
when the existence of neutropenia is unknown.
2 2 Wrong antibiotic
4 Users knowledge of
system state,
modalities.
When entering a new patient identification number
nothing happens.
1 2 None
1The number of usability problems with the same classification path, in the interaction of different or the same user with the system.
2The mentioned outcomes are potential and did not have to occur.
https://doi.org/10.1371/journal.pone.0223073.t001
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for performing physical actions. One of these problems was the inability to review the culture
history when the CDSS had generated an advice. This problem was rated as severity 4,
although it would not lead to a wrong medication selection. The user indicated that this prob-
lem had a great impact on him, because he wanted to review the culture history during the
consultation of an infectious disease specialist when an advice is generated.
Assessment
In total 12 (24%) of the 51 identified usability problems were classified in the assessment phase
(Table 4). These problems concerned the existence, presentation, content and meaning of sys-
tem feedback about the course of the user-interaction and the display of information resulting
from users’ actions.
Not all the problems, that influence the outcome were highly severe problems since three of
the problems potentially resulting in wrong antibiotic selection were assigned severity 2, and
Table 2. Usability problems in the UAF translation phase with their severity and potential effect on task outcome.
ID
No.
Level 1 Level 2 Level 3 Level 4 Description of usability problem No.1 Severity Identifying
potential
outcomes2
5 Translation Existence Existence of
a way
The user calculates, or even guesses, the BMI with a calculator
outside the system.
8 3 Wrong dosage
6 Existence Existence of
a way
The user calculates the needed dosage of gentamicin with a
calculator outside the system. The user mentions that it would
be helpful if the dosage is calculated by the system.
3 4 Wrong dosage
7 Existence Existence of
a way
User has to fill in the weight and body height of the patient.
This information is not automatically retrieved from the
hospital information system. User expresses the wish that
dosage of antibiotic is calculated with automatic retrieved
weight and body height.
1 2 Wrong dosage
8 Existence Existence of
a way
The user has to select a working diagnosis from a drop down
menu. After selecting a working diagnosis it is not clear how to
go back to the previous step in the system.
1 3 None
9 Presentation Perceptual
issues
Noticeability The user does not know (immediately) how to perform a
request for another patient.
4 1 None
10 Presentation Perceptual
issues
Noticeability The user does not use the filter to assemble possible resistant
micro-organisms in the resistance overview profile, which
shows the culture history (if filter is not being used resistant
micro-organisms can be overlooked).
1 0 Wrong antibiotic
11 Presentation Perceptual
issues
Noticeability User does not view the overview of AST3, and the materials (for
example sputum, urine and blood) in the resistance overview
profile which shows the culture history.
2 0 Wrong antibiotic
12 Presentation Perceptual
issues
Noticeability Overview of resistance, which shows the culture history, is not
seen immediately.
1 2 Wrong antibiotic
13 Presentation Perceptual
issues
Noticeability Mouse over info about difference between HAP4 and CAP4 is
not viewed.
3 2 Wrong antibiotic
14 Presentation Perceptual
issues
Noticeability Mouse over info about severity of pneumonia is not viewed.
Argument for severity classification is not correct.
3 2 Wrong antibiotic
15 Presentation Perceptual
issues
Noticeability User overlooks the information provided about the ESBL5
positivity of the patient.
1 0 Wrong antibiotic
1 The number of usability problems with the same classification path, in the interaction of different or the same user with the system.
2The mentioned outcomes are potential and did not have to occur.
3 AST: Antibiotic Susceptibility Tests.
4HAP: hospital acquired pneumonia, CAP: community acquired pneumonia.
5 ESBL: extended spectrum betalactamase
https://doi.org/10.1371/journal.pone.0223073.t002
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one problem assigned severity 1. The UAF classification showed that 4 (33%) of the problems
concerning the assessment phase of interaction were caused by absent or unclear information
displayed after the user’s action to avoid errors. The remaining eight (67%) problems in this
phase were caused by the absence, poor presentation or noticeability of information or feed-
back displayed after the users’ actions.
A general striking finding was that four users indicated that they would not indiscrimi-
nately follow the advice given, because they were aware of the fact that the CDSS was recently
developed and might contain errors.
Discussion
With the augmented scheme for classifying and prioritizing usability problems described by
Khajouej et al. (2011) we found 51 usability problems in different phases of the user system
interaction. Most usability problems were found in the translation phase (55%). Testing the
usability of a CDSS with this scheme proved to be a simple, but effective way to identify usabil-
ity problems and prioritize system redesign efforts. With the use of the augmented UAF the
existence of usability problems, that were not foreseen, were identified. Also, the frequency of
problems of CDSS use, the severity and potential impact of these problems on task outcome
were identified. Assessing usability of a CDSS is important to increase the chance of its
adoption.
This study is the first to report usability testing of a CDSS for empirical antibiotic treatment
in adult patients using the systematic framework developed by Khajouei et al.[27]. A strength
of this study is that we used the standardized and validated UAF, augmented with a severity
rating based on Nielsen’s classification and the assessment of potential effect of the problem
on the task outcome. This approach enables the report of existing usability problems in an
Table 3. Usability problems in the UAF physical action phase with their severity and potential effect on task outcome.
ID
No.
Level 1 Level 2 Level 3 Level
4
Description of usability problem No.1 Severity Identifying
potential
outcomes2
16 Physical
actions
Manipulating
objects
Physical layout To view the complete resistance overview, which shows
the culture history, the user has to scroll down in the
resistance viewer. The user does not scroll down in this
viewer.
1 2 None
17 Manipulating
objects
Preferences and
efficiency
User wants to review the culture history, when advice is
generated, but this is not possible (functionality not
available). User thinks this is not convenient, because the
user wishes to review this history while consulting an
infectious diseases consultant.
1 43 None
18 Manipulating
objects
Preferences and
efficiency
Physician mentions that she misses a button (button does
not exist in the system). There is only the possibility to
answer ‘yes’ or ‘no’ on the question if patient has been
abroad. She mentions there has to be a button
‘unknown’.
1 2 None
19 Perceiving
physical objects
Perceiving objects as
they are being
manipulated
The user tries to click through the resistance viewer,
which shows the culture history. This is not possible (this
functionality is not available in the system)
1 13 None
1The number of usability problems with the same classification path, in the interaction of different or the same user with the system.
2The mentioned outcomes are potential and did not have to occur.
3.The difference in severity between these 2 usability problems stands out. The usability problem ‘The user tries to click through the resistance viewer, which is not
possible’ is scored as 1 (cosmetic problem), because it has a low impact on the user interaction, the problem only occurred once and is an usability problem which is not
persistent.
https://doi.org/10.1371/journal.pone.0223073.t003
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accurate, complete and consistent way. This is needed for guiding and prioritizing system
redesign efforts. Some limitations of this study should also be recognized. Firstly, we could
have missed usability problems because of the small group of participants. However, the group
of 8 participants was a well representative group, composed out of residents from different dis-
ciplines and different years of residence. In addition, about 80% of usability problems can be
discovered with only 8 participants and the more severe a problem is, the more likely it will be
uncovered within the first few subjects [36–38]. Studies to determine the optimal number of
participants for a usability study have shown that the complexity of the study itself is an impor-
tant factor to consider [37, 38]. Because the tasks the user had to perform in our study were
simple and really straightforward we think that 8 participants were enough to detect most
usability problems. Another limitation is that participants may have modified their behavior
and reported thoughts in response to their awareness of being observed during the usability
test. This so-called Hawthorne effect is inherent to simulated usability studies and not possible
to rule out [39]. Because all participants were residents, lack of experience could have contrib-
uted to the existence of certain usability problems. These problems will probably not be experi-
enced by medical specialists. However, given the fact that residents and specialists with not
much experience in antibiotic prescribing, will be the mainly end-users/are the intended users
Table 4. Usability problems in the UAF assessment phase with their severity and potential effect on task outcome.
ID
No.
Level 1 Level 2 Level 3 Level 4 Description of usability problem No.1 Severity Identifying potential
outcomes2
20 Assessment Feedback Content and
meaning
Completeness and
sufficiency of meaning
The user questions what to do with ‘Advice
number’.
1 0 None
21 Information
display
Content and
meaning
Error avoidance The message ‘No relevant cultures known’
is confusing. This message only refers to
cultures in this hospital
2 1 Wrong antibiotic
22 Information
display
Content and
meaning
Error avoidance The user wonders why the resistance
overview includes empty fields.
1 3 Wrong antibiotic
23 Information
display
Content and
meaning
Error avoidance The advice does not clearly indicate for
what antibiotic the trough level has to be
determined.
2 2 Determining
medication dosage for
the wrong antibiotic
24 Information
display
Content and
meaning
Error avoidance Physician reads essential information
accompanying the advice, but prescribes
the wrong antibiotic which is contrary to
this information.
1 2 Wrong antibiotic
25 Information
display
Content and
meaning
Layout and grouping The final advice already appears earlier
under a mouse over (which can be
confusing).
1 2 None
26 Information
display
Content and
meaning
Layout and grouping The resistance overview displays the results
of a bone marrow biopsy, which confuses
the physician.
1 2 Wrong antibiotic
27 Information
display
Existence Human memory aids It is not clear whether the resistance viewer
also takes resistance into account
determined in other hospitals.
1 0 None
28 Information
display
Presentation Perceptual
issues > noticeability
Not clear whether the user realizes the
Gentamicin doses has to be adjusted.
1 2 Wrong dosage
29 Information
display
Presentation Perceptual
issues > noticeability
The physician does not read the text which
states that the Gentamicin dose has to be
adjusted in case of a too high body mass
index.
1 3 Wrong dosage
1The number of usability problems with the same classification path, in the interaction of different or the same user with the system.
2The mentioned outcomes are potential and did not have to occur.
https://doi.org/10.1371/journal.pone.0223073.t004
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of the CDSS, these problems are important to discover and take into account in the system
redesign.
In this usability study participants completed tasks of antimicrobial drug prescription using
four prespecified test cases which were based on real life clinical scenarios. In a setting with
real patients, the physician know his or her patients and can answer certain questions about a
patient better than with the use of a prespecified case, such as the question if the patient has
Fig 2. Some usability problems in the CDSS for empirical antibiotic therapy.
https://doi.org/10.1371/journal.pone.0223073.g002
Fig 3. The resistance viewer in the CDSS for empirical antibiotic therapy and illustration of 2 usability problems.
https://doi.org/10.1371/journal.pone.0223073.g003
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neutropenia. It could therefore be that certain usability problems will not exist or exist less in a
setting with real patients which are known by the user. However, this only applies for usability
problems where continuing in the system is not possible without knowing certain information
(for example neutropenia or if the patient has been abroad). In addition other usability prob-
lems could also be revealed when using this CDSS in real clinical conditions.
With this study we found that some of the residents did not follow the advice that was given
by the CDSS without thought. They were aware of the fact that the CDSS was recently devel-
oped and might contain errors. We also found that time has been invested in the development
of functionalities, which were not (optimally) used. An example is presenting mouse over
information in addition to certain questions, providing relevant information to the user. Our
study showed that these help texts were often not used, which prompted us to enlarge the
information icon that makes this help text appear when moving the cursor towards the infor-
mation icon. Also, simple improvements such as the introduction of a calculator and patient
information that is automatically retrieved from the hospital information system such as
weight and body height are worthwhile investments. Another simple modification we made to
the CDSS is the introduction of a new option, namely the option to review the culture history
in the final screen when an antibiotic advice is generated. With these alterations in the system
design we made the CDSS more specific to users’needs. For ultimate system usability, iterative
usability evaluation during the development and implementation of CDSS are important [28,
40, 41].
Conclusion and recommendations
Our study revealed several usability problems in different phases of the interaction between
the intended user and a CDSS developed for empirical antibiotic treatment, the severity of
these problems and the impact on the task outcome. It shows that even though the CDSS has
been developed by a multidisciplinary team of clinical experts and ICT professionals, many
usability problems can exist that are not foreseen. Assessing usability before CDSS implemen-
tation is recommended for improving CDSS adoption, effectiveness and safety. When design-
ing a CDSS the following elements have to be considered to avoid usability problems:
• ‘When a question has to be answered with a yes or no also provide the answer ‘unknown’. If
answering with yes or no is necessary for the system to generate an advice, provide users
with this information.
• Make it easy to do right by providing calculators for everything that has to be calculated (the
recommended dosage of an antibiotic drug, BMI etc.).
Fig 4. Final screen of the CDSS for empirical antibiotic therapy with a patient specific antibiotic advice.
https://doi.org/10.1371/journal.pone.0223073.g004
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• Retrieve as much information as possible automatically from the hospital information
system.
• Pay attention to the noticeability of relevant information (for example mouse over info with
relevant explanatory information/definitions, resistance overview with information that is
relevant for the final antibiotic advice).
• Provide users with information that is clear and as specific as possible and avoid reporting of
irrelevant, confusing information.
Supporting information
S1 Table. The four test cases that were used to test the usability of the CDSS.
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